HLS Therapeutics (HLS.TO) Q2 2026 Earnings

May 15Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.19
-0.16
-0.12
-0.09

Details

Expected EPS
-0.1644456
Actual EPS
-0.0959266
Surprise EPS
0.07
Surprise Percent
+41.67%

Description

⁨HLS Therapeutics⁩ (⁦HLS.TO⁩) has reported earnings of ⁦-0.0959266⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts